January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Irma Bagdoniene on NEJM-Published VESALIUS-CV: 25% Fewer First CV Events
Nov 10, 2025, 10:47

Irma Bagdoniene on NEJM-Published VESALIUS-CV: 25% Fewer First CV Events

Irma Bagdoniene, Cardiologist and Lipidologist at Klinikum Lippe – University Hospital for Cardiology, Angiology, and Internal Intensive Care Medicine, posted on LinkedIn:

”VESALIUS-CV at AHA:
The Room Was Applauding – And Not Without Reason

Presented at the AHA Congress and now published in NEJM, VESALIUS-CV marks a turning point in preventive cardiology.

In patients without prior MI or stroke, evolocumab reduced first major cardiovascular events by 25% — safely and decisively.

LDL lowering works – and earlier intervention saves lives.
When an entire audience of cardiologists applauds, it’s not hype. It’s the sound of a paradigm shifting.”

Read the full article here.

Title: Evolocumab in Patients without a Previous Myocardial Infarction or Stroke

Authors: Erin A. Bohula, D.Phil., Nicholas A. Marston, Ajay K. Bhatia, Gaetano M. De Ferrari, Lawrence A. Leiter, Jose C. Nicolau, Jeong-Gun Park, Julia F. Kuder, Sabina A. Murphy, Emileigh Walsh, Huei Wang, Vladimir Blaha, Andrzej Budaj, Jan H. Cornel, Assen Goudev, Robert Gabor Kiss, Alberto J. Lorenzatti, Alexander Parkhomenko, Marcoli Cyrille, Gabriel Paiva da Silva Lima, E. Magnus Ohman, Robert P. Giugliano, Marc S. Sabatine

VESALIUS

 

Stay updated with Hemostasis Today.